Dr. Martin Forster is an associate professor at University College London (UCL) and a consultant medical oncologist at University College Hospital. He specializes in thoracic and head and neck cancers, with a strong focus on drug development. His work aims to leverage the growing understanding of cancer biology to identify which patient groups are most likely to benefit from new therapies and drug combinations. As a core member of the lung and head and neck cancer teams, he leads research in clinical trials, serving as principal investigator for over 50 studies, including early-phase trials, immunotherapy research, and solid cancer cell therapies. Dr. Forster collaborates internationally on translational research and holds leadership roles in clinical trials, chemotherapy services, and expert groups focused on cancer treatment.